Safety and Efficacy of FOLFSIM Plus Toripalimab in the Treatment of Advanced or Metastatic Neuroendocrine Carcinoma
Clinical trial NCT03992911 · UNKNOWN
Trial details
- NCT number
- NCT03992911
- Sponsor
- Peking University
- Status
- UNKNOWN
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-06-19
- Primary completion
- 2022-06-20
- Enrollment
- 336
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.